

( (S-HLN (NP-SBJ-1 Genetic Defect)
	 (VP Spotted
	     (NP *-1)
	     (PP-LOC In
		     (NP 3-Day-Old Embryo)))))
( (S (NP-SBJ RESEARCHERS)
     (VP diagnosed
         (NP (NP a genetic defect)
	     (PP-LOC in
		     (NP a three-day-old mouse embryo)))
	 (PP in
	     (NP (NP an experiment)
		 (ADJP directly applicable
		       (PP to
			   (NP humans))))))
     .))
( (S (NP-SBJ (NP Prenatal diagnosis)
             (PP of
                 (NP genetic defects))
             (ADVP-TMP as early
		       (PP as
			   (NP (NP the sixth week)
			       (PP of
				   (NP pregnancy))))))
     (VP is
         (ADJP-PRD increasingly common)
	 (NP-TMP today))
     .))
( (S But
     (NP-SBJ (NP the mouse experiment)
             (PP-LOC at
		     (NP (NP a Medical Research Council laboratory)
			 (PP-LOC in
				 (NP London)))))
     (VP shows
         (SBAR 0
               (S (NP-SBJ-1 genetic defects)
                  (VP can
                      (VP be
                          (VP detected
                              (NP *-1)
                              (PP-TMP (NP-ADV three days)
				      after
				      (NP conception))
                              (S-MNR (NP-SBJ *)
				     (VP using
					 (NP a new American-developed gene-copying technique)))))))))
     .))
( (S (NP-SBJ (NP The experiment)
             ,
             (ADJP applicable
                   (PP to
                       (NP many genetic disorders)))
             ,)
     (VP involved
         (NP (NP beta-thalassemia)
             ,
             (NP (NP a severe blood anemia)
                 (VP resulting
                     (PP-CLR from
			     (NP a missing hemoglobin gene))))))
     .))
( (S (NP-SBJ It)
     (VP 's
         (NP-PRD (NP an inherited human disorder)
                 (SBAR (WHNP-2 that)
                       (S (NP-SBJ-1 *T*-2)
                          (VP 's
                              (VP been
                                  (VP duplicated
                                      (NP *-1)
				      (PP-LOC in
					      (NP mice)))))))))
     .))
( (S (PP-LOC In
	     (NP the experiment))
     ,
     (NP-SBJ-1 (NP mice)
               (PP with
                   (NP the defective gene)))
     (VP were
         (VP mated
             (NP *-1)))
     .))
( (S (ADVP-TMP (NP Three days)
	       later)
     ,
     (SBAR-TMP before
	       (S (NP-SBJ-2 the new embryo)
		  (VP had
		      (VP become
			  (VP implanted
			      (NP *-2)
			      (PP-LOC-CLR in
					  (NP the uterus)))))))
     ,
     (NP-SBJ-1 it)
     (VP was
	 (VP washed
	     (NP *-1)
	     (PP-CLR out
		     (PP of
			 (NP the mother mouse)))))
     .))
( (S (NP-SBJ The embryo)
     (VP had
         (VP progressed
             (PP-CLR (ADVP only)
		     to
		     (NP (NP a clump)
			 (PP of
			     (NP eight identical cells))))))
     .))
( (S (S (NP-SBJ-1 One cell)
        (VP was
            (VP-3 teased
		  (NP *-1)
		  (PRT out))))
     , and
     (S (NP-SBJ=1-2 its DNA)
	(VP=3 extracted
	      (NP *-2)))
     .))
( (S (S-MNR (NP-SBJ *-2)
	    (VP Using
		(NP (NP the new technique)
		    (VP developed
			(NP *)
			(PP by
			    (NP-LGS Cetus Corp.)))
		    ,
		    (VP called
			(S (NP-SBJ *)
			   (NP-PRD the polymerase chain reaction)))
		    ,)))
     (NP-SBJ-2 the scientists)
     (VP (ADVP rapidly)
	 made
	 (NP (NP millions)
	     (PP of
		 (NP (NP copies)
		     (PP of
			 (NP (NP the section)
			     (PP of
				 (NP DNA))
			     (SBAR (WHNP-1 that)
				   (S (NP-SBJ *T*-1)
				      (ADVP ordinarily)
				      (VP contains
					  (NP the hemoglobin gene)))))))))
	 ,
	 (S-ADV (NP-SBJ *-2)
		(VP providing
		    (NP (NP enough copies)
			(SBAR (WHNP-3 0)
			      (S (NP-SBJ *)
				 (VP to
				     (VP test
					 (NP *T*-3)))))))))
     .))
( (S (S-TPC-1 (NP-SBJ A genetic probe)
	      (VP showed
		  (SBAR 0
			(S (NP-SBJ the hemoglobin gene)
			   (VP was
			       (VP missing))))))
     ,
     (NP-SBJ the researchers)
     (VP report
	 (SBAR 0
	       (S *T*-1))
	 (PP-LOC in
		 (NP the medical journal)
		 (NP Lancet)))
     .))
( (S (PP-LOC In
	     (NP the report))
     ,
     (NP-SBJ two molecular biologists)
     (VP suggest
         (SBAR 0
               (S (NP-SBJ-1 such embryo diagnosis)
                  (VP can
                      (VP be
                          (VP used
                              (NP *-1)
                              (PP by
                                  (NP-LGS (NP couples)
					  (PP at
					      (NP (NP high risk)
						  (PP of
						      (S-NOM (NP-SBJ *)
							     (VP passing
								 (NP a genetic defect)
								 (PP-CLR to
									 (NP a child)))))))))))))))
     .))
( (S (PP For
         (NP example))
     ,
     (NP-SBJ (NP infertile couples)
             (SBAR (WHNP-1 who)
                   (S (NP-SBJ *T*-1)
                      (VP have
                          (S (NP-SBJ-2 (NP the woman 's)
				       eggs)
			     (VP fertilized
				 (NP *-2)
				 (PP-LOC in
					 (NP the test tube))))))))
     (ADVP usually)
     (VP have
         (S (NP-SBJ-3 (NP several eggs)
		      (PP-TMP *ICH*-4))
	    (VP fertilized
		(NP *-3)
		(PP-TMP-4 at
			  (NP a time)))))
     .))
( (S (SBAR-TMP (WHADVP-2 When)
	       (S (NP-SBJ the fertilized cells)
		  (VP divide
		      (PP-CLR to
			      (NP eight cells))
		      (ADVP-TMP *T*-2))))
     ,
     (NP-SBJ-1 (NP a single cell)
               (PP from
                   (NP each embryo)))
     (VP can
         (VP be
             (VP tested
                 (NP *-1)
                 (PP-CLR for
			 (NP genetic defects)))))
     .))
( (S (S (NP-SBJ-1 A healthy embryo)
        (VP can
            (VP be
                (VP-3 picked
		      (NP *-1)
		      (PP-PRP for
			      (NP implantation))))))
     and
     (S (NP-SBJ=1-2 defective ones)
	(VP=3 discarded
	      (NP *-2)))
     .))
( (S Or
     (PP-LOC in
	     (NP other couples))
     ,
     (NP-SBJ-1 the embryo)
     (VP could
         (VP be
             (VP (VP (VP (ADVP-TMP temporarily)
                         taken 
			 (NP *-1)
			 (PRT out))
                     and
                     (VP tested
			 (NP *-1))
                     (PP-TMP (NP-ADV three days)
			     after
			     (NP conception)))
                 and
                 (VP (VP returned
			 (NP *-1)
			 (SBAR-PRP if
				   (S (NP-SBJ *-1) 
				      (ADJP-PRD healthy)))
                         ,)
                     or
                     (VP discarded
			 (NP *-1)
                         (SBAR-PRP if 
				   (X not)))))))
     .))
( (S-HLN (NP-SBJ-1 Yeast)
	 (VP Adapted
	     (NP *-1)
	     (S-PRP (NP-SBJ *)
		    (VP to
			(VP Make
			    (NP Gene-Spliced Drugs)))))))
( (S (NP-SBJ AN OIL COMPANY)
     (VP finds
         (NP a sideline)
	 (PP-LOC in
		 (NP (NP the microscopic world)
		     (PP of
			 (NP yeast)))))
     .))
( (S (PP-TMP In
	     (NP the early 1970s))
     ,
     (SBAR-TMP (WHADVP-1 when)
	       (S (NP-SBJ the `` world food crisis '')
		  (VP was
		      (NP-PRD a major worry)
		      (ADVP-TMP *T*-1))))
     ,
     (NP-SBJ-2 Phillips Petroleum Co.)
     ,
     (PP like
         (NP several other big companies))
     ,
     (VP began
         (S (NP-SBJ *-2)
            (VP developing
                (NP ``
                    (NP single-cell protein)
                    , ''
                    (NP (NP edible protein)
                        (VP made
                            (NP *)
                            (PP by
                                (NP-LGS (NP microbes)
                                        (VP feeding
                                            (PP-CLR on
						    (NP non-edible materials)))))))))))
     .))
( (S (NP-SBJ Phillips)
     (VP found and improved
         (NP (NP a yeast)
             , ``
             (NP Pichia pastoris)
             , ''
             (SBAR (WHNP-1 which)
                   (S (NP-SBJ *T*-1)
                      (VP made
                          (NP protein)
                          (PP-MNR from
				  (NP natural gas-derived alcohol)))))))
     .))
( (S (NP-SBJ It)
     (ADVP also)
     (VP could
         (VP convert
             (NP (NP glucose)
		 (PP from
		     (NP farm wastes)))
	     (PP-CLR into
		     (NP edible protein))))
     .))
( (S (S (NP-SBJ Single-cell protein)
        (ADVP-TMP never)
        (VP panned 
	    (PRT out)))
     , and
     (S (NP-SBJ most companies)
        (VP abandoned
            (NP such research)))
     .))
( (S But
     (NP-SBJ-1 Phillips)
     (VP persisted
	 ,
	 (S-ADV (NP-SBJ *-1)
		(VP calling 
		    (PRT in)
		    (NP (NP scientists)
			(PP from
			    (NP the Salk Institute))))))
     .))
( (S (NP-SBJ They)
     (VP 've
         (ADVP-TMP now)
         (VP adapted
             (NP the yeast)
             (PP-CLR to
		     (S-NOM (NP-SBJ *)
			    (VP making
				(NP (ADJP genetically engineered)
				    drugs))))))
     .))
( (S (PP Like
         (NP (NP the bacteria)
             (VP used
                 (NP *)
                 (PP by
                     (NP-LGS genetic engineers)))))
     ,
     (NP-SBJ the yeast)
     (VP can
         (VP (VP take 
		 (PRT in)
                 (NP human genes))
             and
             (VP churn 
		 (PRT out)
                 (NP (NP human proteins)
                     (PP for
                         (NP medical use))))))
     .))
( (S But
     (NP-SBJ the yeast genetic apparatus)
     (VP is
         (PP-PRD (PP (ADVP more)
		     like
		     (NP (NP that)
			 (PP of
			     (NP animals))))
                 (PP than
                     (NP the bacterial genetic apparatus))))
     .))
( (S (ADVP Thus)
     ,
     (NP-SBJ (NP the proteins)
             (PP from
                 (NP the yeast)))
     (VP are
         (PP-PRD (PP (ADVP molecularly) 
		     (ADVP more)
		     like
		     (NP human proteins))
                 (PP than
                     (NP (NP those)
                         (PP from
                             (NP bacteria))))))
     .))
( (S (NP-SBJ The oil company)
     (VP claims
         (SBAR 0
               (S (NP-SBJ its yeast system)
                  (ADVP also)
                  (VP is
                      (ADJP-PRD better
                                (PP than
                                    (NP bacteria))
                                (PP at
                                    (NP (NP high-volume production)
                                        (PP of
                                            (NP (ADJP genetically engineered)
                                                drugs)))))))))
     .))
( (S (NP-SBJ (NP Chiron Corp.)
             ,
             (NP an
                 (NAC-LOC Emeryville
			  ,
			  Calif.
			  ,)
                 biotechnology firm)
             ,)
     (VP is
         (VP seeing
             (SBAR if
		   (S (NP-SBJ-1 the Phillips yeast)
		      (VP can
			  (VP be
			      (VP used
				  (NP-2 *-1)
				  (S-CLR (NP-SBJ *-2)
					 (VP to
					     (VP make
						 (NP its
						     (ADJP genetically engineered)
						     human proteins)))))))))))
     .))
( (S (NP-SBJ *)
     (VP Peeking
         (PP-LOC Inside
		 (NP Arteries))
         (PP From
             (PP Outside
                 (NP the Body))))))
( (S (S-NOM-SBJ (NP-SBJ *)
		(VP VISUALIZING
		    (NP BLOOD vessels)
		    (PP-MNR without
			    (S-NOM (NP-SBJ *)
				   (VP poking
				       (NP catheters)
				       (PP-CLR into
					       (NP the body)))))))
     (VP may
         (VP come
             (PP-CLR out
		     (PP of
			 (NP (NP research)
			     (PP-LOC at
				     (NP AT&T Bell Laboratories)))))))
     .))
( (S (NP-SBJ (NP Strokes)
             ,
             (NP heart attacks)
             ,
             (NP (NP leg pains)
                 (PRN -LRB-
		      (NP intermittent claudication)
		      -RRB-))
             and
             (NP other problems))
     (VP stem
         (PP-CLR from
		 (NP (NP clogging)
		     (PP of
			 (NP the arteries))
		     (PP by
			 (NP cholesterol-rich deposits)))))
     .))
( (S (PP-TMP At
	     (NP present))
     ,
     (NP-SBJ-4 doctors)
     (VP can
         (VP see
             (SBAR (WHADVP-3 how badly)
                   (S (NP-SBJ-1 an artery)
                      (VP is
                          (VP clogged
                              (NP *-1)
			      (ADVP-MNR *T*-3)))))
             (PP-MNR (ADVP only)
		     by
		     (S-NOM (NP-SBJ *-4)
			    (VP (VP inserting
				    (NP a thin catheter)
				    (PP-CLR into
					    (NP the artery)))
				and
				(VP injecting
				    (NP (NP a fluid)
					(SBAR (WHNP-2 that)
					      (S (NP-SBJ *T*-2)
						 (VP makes
						     (S (NP-SBJ the arteries)
							(ADJP-PRD visible
								  (PP on
								      (NP X-rays))))))))))))))
     .))
( (S (NP-SBJ-1 A
               (ADJP non-invasive)
               method)
     (VP is
         (VP being
             (VP researched
                 (NP *-1)
                 (PP by
                     (NP-LGS biophysicist
			     Lynn Jelinski))
                 (PP-LOC at
			 (NP the AT&T unit)))))
     .))
( (S (NP-SBJ It)
     (VP relies
         (PP-CLR on
		 (NP the fact
		     (SBAR that
			   (S (NP-SBJ certain atoms)
			      (VP give 
				  (PRT off)
				  (NP detectable signals)
				  (SBAR-TMP (WHADVP-2 when)
					    (S (NP-SBJ-1 *)
					       (VP subjected
						   (NP *-1)
						   (PP-CLR to
							   (NP an intense magnetic field))
						   (ADVP-TMP *T*-2))))))))))
     .))
( (S (NP-SBJ It)
     (VP 's
         (NP-PRD (NP the same phenomenon)
                 (VP used
                     (NP *)
                     (PP-CLR in
			     (NP (NP the new MRI (PRN -LRB- magnetic resonance imaging -RRB-) scanners)
				 (VP being
				     (VP used
					 (NP *)
					 (PP-LOC in
						 (NP hospitals))
					 (PP in 
					     (NP (NP place)
						 (PP of
						     (NP X-ray scans)))))))))))
     .))
( (S (PP-LOC In
	     (NP the Bell Labs experiments))
     ,
     (NP-SBJ (NP (NP an MRI-type)
                 (PP of
                     (NP machine)))
             ,
             (VP synchronized
                 (NP *)
                 (PP-CLR with
			 (NP the heartbeat))
                 (PP-MNR via
			 (NP an electrocardiogram)))
             ,)
     (VP (ADVP rapidly)
         flashes
         (NP a magnetic field)
         (PRT on and off)
	 (SBAR-ADV as
		   (S (NP-SBJ blood)
		      (VP passes
			  (NP (NP a certain point)
			      (PP-LOC in
				      (NP a vessel)))))))
     .))
( (S (NP-SBJ (NP The
		 (ADJP rapidly
		       flashing)
		 return signals)
             (PP from
                 (NP (NP excited hydrogen atoms)
                     (PP-LOC in
			     (NP the blood)))))
     (VP give
         (NP (NP a `` stop-motion '' movie)
             (PP of
                 (NP the blood-filled vessel))
             , 
	     (PRN -LRB-
		  (PP like
		      (NP (NP the `` stop-motion '')
			  (VP seen
			      (NP *)
			      (PP-LOC in
				      (NP disco dancers))
			      (SBAR-TMP (WHADVP-1 when)
					(S (NP-SBJ a strobe light)
					   (VP is
					       (VP flashing
						   (ADVP-TMP *T*-1))))))))
		  -RRB-)))
     .))
( (S (NP-SBJ The scientists)
     (VP have
         (VP experimented
             (PP-CLR on
		     (NP (NP the tiny neck arteries)
			 (PP of
			     (NP rats))))))
     .))
( (S (S-TPC-2 (NP-SBJ-1 They)
	      (VP 've
		  (VP been
		      (ADJP-PRD able
				(S (NP-SBJ *-1)
				   (VP to
				       (VP (VP measure
					       (NP (NP the minuscule movements)
						   (PP of
						       (NP the artery wall)))
					       (SBAR-TMP as
							 (S (NP-SBJ the beating heart)
							    (VP raises and lowers
								(NP (NP the pressure)
								    (PP of
									(NP the flowing blood)))))))
					   ,
					   (NP (NP a first)
					       (PP for
						   (NP (ADJP such tiny)
						       blood vessels))))))))))
     ,
     (NP-SBJ they)
     (VP report
	 (SBAR 0
	       (S *T*-2))
	 (PP-LOC in
		 (NP (NP Nature)
		     ,
		     (NP a scientific journal))))
     .))
( (S (NP-SBJ They)
     (ADVP-TMP now)
     (VP are
         (VP experimenting
             (PP-CLR with
		     (S-NOM (NP-SBJ *)
			    (VP measuring
				(NP blood flow))))))
     .))
( (S (NP-SBJ The ultimate hope)
     (VP is
         (SBAR-PRD that
                   (S (NP-SBJ the technique)
                      (VP could
                          (VP identify
                              (NP diseased vessels))))))
     .))
( (NP-HLN Odds and Ends))
( (S (S-TPC-1 (NP-SBJ (NP TESTS)
		      (PP ON
			  (NP (NP 2,800-year-old mummies)
			      (PP from
				  (NP Chile)))))
	      (VP indicate
		  (SBAR 0
			(S (NP-SBJ ancient wood fires)
			   (VP did n't
			       (VP produce
				   (NP dioxins or dibenzofurans)))))
		  ,
		  (S-ADV (NP-SBJ *)
			 (VP contradicting
			     (NP a theory
				 (SBAR 0
				       (S (NP-SBJ the two pollutants)
					  (NP-TMP today)
					  (VP are
					      (VP coming
						  (PP-CLR from
							  (NP wood burning)))))))))))
     ,
     (NP-SBJ General Electric Co.)
     (VP reports
	 (SBAR 0
	       (S *T*-1))
	 (PP-LOC in
		 (NP Environmental Science & Technology magazine)))
     ...
     .))
( (SINV (S-TPC-2 (NP-SBJ (NP (QP Almost 40) %)
			 (PP of
			     (NP schizophrenic men))
			 (PP *ICH*-1))
		 (VP have
		     (NP (NP an impaired sense)
			 (PP of
			     (NP smell)))
		     (PP-1 vs.
			   (NP (NP (QP fewer
				       than
				       10) %)
			       (PP of
				   (NP schizophrenic women))))))
	,
	(VP reports
	    (SBAR 0
		  (S *T*-2)))
	(NP-SBJ (NP the American Journal)
		(PP of
		    (NP Psychiatry)))
	.))
